Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications

Virology Journal

Volumn 8, Issue , 2011, Pages

  Yang, Chunfu ^a   Deng, Chaoyang ^a   Wan, Junfeng ^b   Zhu, Liye ^b   Leng, Qibin ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b Center for Disease Control of Fuyang City   (China)

Author keywords

cellular immune response; EV71; hand, foot and mouth disease; neutralizing antibody; vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROVIRUS 71; HAND FOOT AND MOUTH DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; ADULT; BLOOD; CHINA; DNA SEQUENCE; ENTEROVIRUS; GENETICS; GENOTYPE; HOSPITALIZATION; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PATHOLOGY; TIME;

HUMAN ENTEROVIRUS 71;

ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; CHINA; ENTEROVIRUS A, HUMAN; GENOTYPE; HAND, FOOT AND MOUTH DISEASE; HUMANS; INFANT; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 79959226189     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-306     Document Type: Article

References (28)

1. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. M Chumakov M Voroshilova L Shindarov I Lavrova L Gracheva G Koroleva S Vasilenko I Brodvarova M Nikolova S Gyurova,, et al. Arch Virol 1979 60 329 340 10.1007/BF01317504 228639 (Pubitemid 9221445)
2. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. G Nagy S Takatsy E Kukan I Mihaly I Domok, Arch Virol 1982 71 217 227 10.1007/BF01314873 6285858 (Pubitemid 12072656)
3. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. LG Chan UD Parashar MS Lye FG Ong SR Zaki JP Alexander KK Ho LL Han MA Pallansch AB Suleiman,, et al. Clin Infect Dis 2000 31 678 683 10.1086/314032 11017815 (Pubitemid 32295486)
4. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. CY Chong KP Chan VA Shah WY Ng G Lau TE Teo SH Lai AE Ling, Acta Paediatr 2003 92 1163 1169 10.1111/j.1651-2227.2003.tb02478.x 14632332 (Pubitemid 37297096)
5. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. M Ho ER Chen KH Hsu SJ Twu KT Chen SF Tsai JR Wang SR Shih, N Engl J Med 1999 341 929 935 10.1056/NEJM199909233411301 10498487 (Pubitemid 29441546)
6. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. T Fujimoto M Chikahira S Yoshida H Ebira A Hasegawa A Totsuka O Nishio, Microbiol Immunol 2002 46 621 627 12437029
7. Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000. YM Jee DS Cheon K Kim JH Cho YS Chung J Lee SH Lee KS Park JH Lee EC Kim,, et al. Arch Virol 2003 148 1735 1746 10.1007/s00705-003-0133-6 14505086 (Pubitemid 37144177)
8. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. PV Tu NT Thao D Perera TK Huu NT Tien TC Thuong OM How MJ Cardosa PC McMinn, Emerg Infect Dis 2007 13 1733 1741 18217559 (Pubitemid 350126202)
9. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. Y Zhang XJ Tan HY Wang DM Yan SL Zhu DY Wang F Ji XJ Wang YJ Gao L Chen,, et al. J Clin Virol 2009 44 262 267 10.1016/j.jcv.2009.02.002 19269888
10. Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Z Zhu S Zhu X Guo J Wang D Wang D Yan X Tan L Tang H Zhu Z Yang,, et al. Virol J 2010 7 300 10.1186/1743-422X-7-300 21050463
11. A comparison of the biological characteristics of EV71 C4 subtypes from different epidemic strains. LC Wang SQ Tang YM Li HL Zhao CH Dong PF Cui SH Ma Y Liao LD Liu QH Li, Virol Sin 2010 25 98 106 10.1007/s12250-010-3102-8 20960306
12. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. HL Chen JY Huang TW Chu TC Tsai CM Hung CC Lin FC Liu LC Wang YJ Chen MF Lin CM Chen, Vaccine 2008 26 2882 2889 10.1016/j.vaccine.2008.03.041 18450335
13. Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield. CY Chung CY Chen SY Lin YC Chung HY Chiu WK Chi YL Lin BL Chiang WJ Chen YC Hu, Vaccine 2010 28 6951 6957 10.1016/j.vaccine. 2010.08.052 20797455
14. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. KC Ong S Devi MJ Cardosa KT Wong, J Virol 2010 84 661 665 10.1128/JVI.00999-09 19864378
15. EV71: an emerging infectious disease vaccine target in the Far East? J Xu Y Qian S Wang JM Serrano W Li Z Huang S Lu, Vaccine 2010 28 3516 3521 10.1016/j.vaccine.2010.03.003 20304038
16. Enterovirus 71 vaccine: close but still far. D Zhang J Lu, Int J Infect Dis 2010 14 739 743 10.1016/j.ijid.2009.12.002 20400350
17. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. M Arita H Shimizu N Nagata Y Ami Y Suzaki T Sata T Iwasaki T Miyamura, J Gen Virol 2005 86 1391 1401 10.1099/vir.0.80784-0 15831951 (Pubitemid 40613257)
18. Report on the Hand, Foot and Mouth Disease Outbreak in Fuyang City, Anhui Province and the Prevention and Control in China. WHO, 2008 1 25
19. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. SM Wang HY Lei MC Huang JM Wu CT Chen JN Wang JR Wang CC Liu, Pediatr Pulmonol 2005 39 219 223 10.1002/ppul.20157 15635619
20. Seroepidemiology of human enterovirus 71, Singapore. EE Ooi MC Phoon B Ishak SH Chan, Emerg Infect Dis 2002 8 995 997 12194783 (Pubitemid 35000825)
21. Presence of high-titer neutralizing antibodies against enterovirus 71 in intravenous immunoglobulin manufactured from Chinese donors. R Cao J Han Y Deng M Yu E Qin C Qin, Clin Infect Dis 2010 50 125 126 20001529
22. Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71. ML Huang PS Chiang ST Luo GY Liou MS Lee, J Virol Methods 2010 165 42 45 10.1016/j.jviromet.2009.12.015 20036286
23. Seroprevalence and molecular epidemiology of enterovirus 71 in Germany. S Diedrich A Weinbrecht E Schreier, Arch Virol 2009 154 1139 1142 10.1007/s00705-009-0413-x 19506798
24. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. HF Rabenau M Richter HW Doerr, Med Microbiol Immunol 2010 199 45 51 10.1007/s00430-009-0133-6 19941005
25. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. LY Chang CA Hsiung CY Lu TY Lin FY Huang YH Lai YP Chiang BL Chiang CY Lee LM Huang, Pediatr Res 2006 60 466 471 10.1203/01.pdr.0000238247.86041.19 16940249 (Pubitemid 44427602)
26. Neutralizing antibodies to enterovirus 71 in Belem, Brazil. L Gomes Mde CM de Castro MJ Oliveira EE da Silva, Mem Inst Oswaldo Cruz 2002 97 47 49 12426594 (Pubitemid 135746202)
27. Acute encephalitis caused by intrafamilial transmission of enterovirus 71 in adult. T Hamaguchi H Fujisawa K Sakai S Okino N Kurosaki Y Nishimura H Shimizu M Yamada, Emerg Infect Dis 2008 14 828 830 10.3201/eid1405.071121 18439374 (Pubitemid 351838655)
28. HLA-A33 is associated with susceptibility to enterovirus 71 infection. LY Chang IS Chang WJ Chen YC Huang GW Chen SR Shih JL Juang HM Shih CA Hsiung TY Lin LM Huang, Pediatrics 2008 122 1271 1276 10.1542/peds.2007-3735 19047245